News

Pharmacist guidance issued on managing bowel cancer

17-May-07

Colon cancer
New guidance on the best practice for pharmacists when advising on suspected, or diagnosed, bowel cancer has been prepared.

The guidance has been produced by the national charity Beating Bowel Cancer and supported by the Royal Pharmaceutical Society of Great Britain (RPSGB). The guidance for pharmacists, which will be distributed in the 19 May edition of the Pharmaceutical Journal, is part of a broader campaign, spearheaded by Beating Bowel Cancer.

The new campaign is being piloted in 11 primary care trusts across England. Part of the initiative is to provide pharmacy staff and their customers with important information on symptoms to look out for, and encouraging customers to seek further support if they are concerned.

The guidance will be available online at the RPSGB website and the Beating Bowel Cancer website.

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

Professional development - Membership of the RCGP

Dr Sathya Naidoo explains the criteria that are required for completing iMAP. Read more

How to apply for your certificate

Applying to the RCGP for your CCT recommendation now takes three clicks, writes Fiona Erasmus. Read more

A question of capacity

Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more

Show all articles

 

Latest Clinical Articles

Stable angina pectoris

Section 1 Definition and pathophysiology Read more

Endometriosis

Contributed by Mr Michael Booker, consultant obstetrician & gynaecologist, and fertility specialist ... Read more

Primary hyperparathyroidism

Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more

Show all clinical articles

MIMS Product News

Toviaz

New drug - Toviaz

Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more

New drug - Tasigna

Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more

Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more

Jobs

 

Job of the Week